Skip to main content
Premium Trial:

Request an Annual Quote

Falling Behind

Research on human embryonic stem cells should absolutely get federal funding, writes David Scadden in a column for the Boston Globe. The co-director of the Harvard Stem Cell Institute says that the US is losing out when it comes to stem cells, as funding controversies are forcing some researchers to halt their work and others to leave the country to work overseas. "That the United States has been attractive to the world’s scientific talent is in no small part because our government has invested courageously in big challenges. The new pattern — of fitful stops and starts in support for an area with potential to change medicine — puts us more in the ranks of the feckless than the fearless," Scadden says, adding that the loss of young stem cell researchers would "cost us all." Genome Technology has more on the stem cell research funding conundrum in its November issue cover story, here.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.